Trial Profile
A Phase II efficacy study cannabinoid-based ointment for the treatment of Psoriasis: Psoriasis Study
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2019
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors One World Cannabis
- 05 Aug 2019 According to an OWC Pharmaceutical Research Corp media release, currently, this study is planned to be conducted at the Kaplan Medical Center, an academic medical center in Israel.
- 05 Aug 2019 According to an OWC Pharmaceutical Research Corp media release, it received long-awaited approval from the Israeli Medical Cannabis Agency to conduct this trial.
- 30 Jan 2019 According to an OWC Pharmaceutical Research Corp media release, this study is expected to initiate during the third quarter 2019.